Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Fortrea Holdings Inc.
FTRECurrent price
19.34 USD
-0.77 USD (-3.83%)
Last closed
20.2 USD
Company
–
ISIN
US34965K1079
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 107 949 952 USD
Yield for 12 month
-40.38 %
1Y
3Y
5Y
10Y
15Y
FTRE
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. Address: 8 Moore Drive, Durham, NC, United States, 27709
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
23.4 USDP/E ratio
–Dividend Yield
–Current Year
+3 109 000 000 USD
Last Year
+3 096 100 000 USD
Current Quarter
+575 600 000 USD
Last Quarter
+662 400 000 USD
Current Year
+520 400 000 USD
Last Year
+621 700 000 USD
Current Quarter
-713 500 000 USD
Last Quarter
+115 700 000 USD
Key Figures FTRE
1 year
3 years
5 years
10 years
EBITDA
22 200 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-1.05 %
PEG Ratio
–
Return On Equity TTM
-13.59 %
Wall Street Target Price
23.4 USD
Revenue TTM
2 975 600 128 USD
Book Value
16.87 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-13.1 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.44 USD
Diluted Eps TTM
-2.44 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-57.4 %
Profit Margin
-10.08 %
Dividend Analytics FTRE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History FTRE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation FTRE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
384.6154
Enterprise Value Revenue
1.0776
Price Sales TTM
0.7084
Enterprise Value EBITDA
451.6268
Price Book MRQ
1.3928
Financials FTRE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators FTRE
For 52 weeks
16.53 USD
41.02 USD
50 Day MA
19.7 USD
Shares Short Prior Month
7 292 843
200 Day MA
27.86 USD
Short Ratio
3.69
Shares Short
7 287 605
Short Percent
11.74 %
BeatStart